跳至主要内容
临床试验/NL-OMON42260
NL-OMON42260已完成不适用

Pilot study: The retina as a potential window to visualize neuropathology in Alzheimer's disease. - Is Alzheimer's disease visible in the eye?

Vrije Universiteit Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Study cases: Patients with early onset (<70 years) AD according to the NINCDS/ADRDA criteria. The patients need to be fully capacitated and able to give informed consent, with a minimum MMSE-score of 17/30 (according to other AD-protocols);- Controls: patients with subjective memory complaints visiting the Alzheimer center, without diagnosis of AD or other neurodegenerative disease.

排除标准

  • - Patients with neuro-opthalmological conditions, which may interfere with the OCT and/or FAF data will be excluded (Table 2, Tewarie et al., 2012).
  • - Patients with progressive dementia, with an MMSE below 17/30 and/or incapacitated and not capable to give informed consent
  • - Patients with a narrow anterior angle of the eye and/or increased intra-ocular pressure. These patients have a contra-indication to use mydriatic agents.

研究者

相似试验

Pilot study: The retina as a potential window to... | 临床试验